Rubella Virus Vaccine |
|
VAC-0323 |
Creative BioMart |
0.5ml |
EUR 1598.4 |
|
Description: Protein |
Cytomegalovirus Antibody Laboratories manufactures the cmv virus vaccine reagents distributed by Genprice. The Cmv Virus Vaccine reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact cytomegalovirus Antibody. Other Cmv products are available in stock. Specificity: Cmv Category: Virus Group: Vaccine
Yellow Fever Virus Vaccine Serum: Pre-Vaccination Bleed |
|
The Native Antigen Company |
1ml |
EUR 547.21 |
|
Description: Liquid preparation of serum obtained from a recipient of Yellow Fevervaccine (17D strain), prior to their immunisation. |
Yellow Fever Virus Vaccine Serum: Pre-Vaccination Bleed |
|
The Native Antigen Company |
0.5ml |
EUR 357.94 |
|
Description: Liquid preparation of serum obtained from a recipient of Yellow Fevervaccine (17D strain), prior to their immunisation. |
Vaccine information
Yellow Fever Virus Vaccine Serum: 6 Week (IgG) Bleed |
|
SER71202-500 |
The Native Antigen Company |
0.5ml |
EUR 357.94 |
|
Description: Liquid preparation of serum obtained from a recipient of Yellow Fever vaccine (17D strain), 6 weeks post immunisation. |
Yellow Fever Virus Vaccine Serum: 6-month (IgG) bleed |
|
SER71206-1000 |
The Native Antigen Company |
1ml |
EUR 547.21 |
|
Description: Serum obtained from a recipient of Yellow Fever vaccine (17D strain), 6 months post immunisation. |
Yellow Fever Virus Vaccine Serum: 6-month (IgG) bleed |
|
SER71206-500 |
The Native Antigen Company |
0.5ml |
EUR 357.94 |
|
Description: Serum obtained from a recipient of Yellow Fever vaccine (17D strain), 6 months post immunisation. |
Yellow Fever Virus Vaccine Serum: Pre-Vaccination Bleed |
|
SER71200-1000 |
The Native Antigen Company |
1ml |
EUR 547.21 |
|
Description: Liquid preparation of serum obtained from a recipient of Yellow Fevervaccine (17D strain), prior to their immunisation. |
Yellow Fever Virus Vaccine Serum: Pre-Vaccination Bleed |
|
SER71200-500 |
The Native Antigen Company |
0.5ml |
EUR 357.94 |
|
Description: Liquid preparation of serum obtained from a recipient of Yellow Fevervaccine (17D strain), prior to their immunisation. |
Japanese Encephalitis Virus Vaccine Serum: Pre-Vaccination Bleed |
|
SER71207-1000 |
The Native Antigen Company |
1ml |
EUR 547.21 |
|
Description: Serum obtained from a recipient of Japanese Encephalitis vaccine, prior to their immunisation. |
Japanese Encephalitis Virus Vaccine Serum: Pre-Vaccination Bleed |
|
SER71207-500 |
The Native Antigen Company |
0.5ml |
EUR 547.21 |
|
Description: Serum obtained from a recipient of Japanese Encephalitis vaccine, prior to their immunisation. |
Rabies virus Glycoprotein G ELISA Kit (For Vaccine Development) |
|
RAS-A167 |
ACROBIOSYSTEMS |
96tests |
EUR 643.1 |
|
|
|
Description: Rabies virus (RABV), scientific name Rabies lyssavirus, is a deadly neurotropic virus that causes rabies in humans and animals. Rabies virus has an extremely wide host range and its transmission most often occur through the saliva of animals. Without intervention prior to disease progression, rabies has the highest case fatality of any infectious disease. RABV contains a single-stranded negative-sense R genome that encodes five structural proteins: nucleoprotein (N), phosphoprotein (P), matrix protein (M), glycoprotein (G), and R-dependent R polymerase (L). Among these viral proteins, the RABV glycoprotein (RABV-G) is a pivotal player mediating virus entry and the major target of neutralizing antibodies, thus a key factor for vaccine and drug design.A rapid and effective assay kit detecting the levels ofRABV-G is urgently needed to accelerate the development of RABV vaccines. |
Rabbit Anti-West Nile Virus (WNV vaccine/Innovator, inactivated) antiserum |
|
WNV12-S |
Alpha Diagnostics |
100 ul |
EUR 548.4 |
Rabbit anti-Mumps virus (strain Miyahara vaccine)(MuV) HN Polyclonal Antibody |
|
MBS7152143-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to West Nile Virus vaccines (WNV-ENV/NS1/prM) vaccine by ELISA |
|
910-360-CUX |
Alpha Diagnostics |
Custom |
Ask for price |
Rabbit Anti-Zaire Ebola virus nucleoprotein (EBOV NP, 1-739/DNA vaccine) IgG |
|
EVNP13-A |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Mumps virus (strain Miyahara vaccine) (MuV) HN Protein, His Tag (MALS & SPR verified) |
|
HNN-M52H3 |
ACROBIOSYSTEMS |
500ug |
EUR 490.5 |
|
|
|
Description: Mumps virus (strain Miyahara vaccine) (MuV) HN Protein, His Tag (HNN-M52H3) is expressed from human 293 cells (HEK293). It contains AA Gly 106 - Thr 582 (Accession # P11235). |
Varicella Zoster Virus Glycoprotein E (VZV gE) ELISA Kit (For Vaccine Development) |
|
RAS-A135 |
ACROBIOSYSTEMS |
96tests |
EUR 643.1 |
|
|
|
Description: Varicella-zoster virus (VZV) the etiologic agent of chickenpox and herpes zoster [HZ], is highly contagious and still endemic worldwide. Glycoprotein E (gE) is one of the known glycoproteins (gB, gC, gE, gH, gI, gK, gI) of VZV that is most abundantly expressed on the surface of virus and infected cells, playing an important role in viral replication and cell-to-cell spread. The strongly immunogenic gE can provide strong IgG signal in body fluid, which makes it ideal to be developed as an antigen for analysis of Immunogenicity in the development of VZV vaccine.Therefore,It's helpful to develop the Varicella Zoster Virus Glycoprotein E (VZV gE) ELISA Kit to quantitative detection the VZV gE antigen in vaccine samples during the manufacture and quality control of vaccine development. |
Zika Virus (ZIKV) Envelop protein ELISA kit for vaccine testing, 48 tests, Quantitative |
|
RV-403001-ENV-48 |
Alpha Diagnostics |
1 Kit |
EUR 1000.8 |
Mumps virus (strain Miyahara vaccine) (MuV) Fusion glycoprotein F0, His Tag (MALS verified) |
|
RSF-V52H4 |
ACROBIOSYSTEMS |
50ug |
EUR 3084.7 |
|
|
|
Description: Mumps virus (strain Miyahara vaccine) (MuV) Fusion glycoprotein F0, His Tag (RSF-V52H4) is expressed from human 293 cells (HEK293). It contains AA Val 20 - ILe 486 (Accession # P11236(FAGIAIGIA 103-111del)). |
Zika Virus NS1 (ZIKV-NS1) protein ELISA kit for vaccine testing, 96 tests, Quantitative |
|
RV-403301-NS1-48 |
Alpha Diagnostics |
1 Kit |
EUR 1000.8 |
Rabbit Anti-Zaire Ebola virus glycoprotein (Mayinga/GP, 1-676aa/DNA vaccine) IgG, purified |
|
EVGP15-A |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Rabbit Anti-Zaire Ebola virus glycoprotein (Mayinga/GP 1-652aa/DNA vaccine) IgG, purified |
|
EVGP16-A |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Varicella zoster virus (strain Oka vaccine) Envelope Glycoprotein E (gE), His Tag (MALS verified) |
|
GLE-V52H3 |
ACROBIOSYSTEMS |
100ug |
EUR 2180 |
|
|
|
Description: Varicella zoster virus (strain Oka vaccine) Envelope Glycoprotein E (gE), His Tag (GLE-V52H3) is expressed from human 293 cells (HEK293). It contains AA Ser 31 - Ala 546 (Accession # Q9J3M8-1). |
Rabbit Anti-Marburg virus glycoprotein GP (MARV GP 26-649 aa/Popp/DNA vaccine) IgG, aff pure |
|
MVGP18-A |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Rabbit Anti-Zaire Ebola virus glycoprotein (Cote dIvoire/GP, 1-672aa/DNA vaccine) IgG, purified |
|
EVGP24-A |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Tick Borne Encephalitis Virus (whole virus/TBEV/FSME) vaccine by ELISA |
|
990-100-CUX |
Alpha Diagnostics |
Custom |
Ask for price |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Tick Borne Encephalitis Virus (whole virus/TBEV/FSME) vaccine by ELISA |
|
960-800-CUX |
Alpha Diagnostics |
Custom |
Ask for price |
Rabbit Anti-Marburg virus glycoprotein GP (MARV GP 26-649 aa/Muskoe/DNA vaccine) IgG, aff pure |
|
MVGP17-A |
Alpha Diagnostics |
100 ul |
EUR 578.4 |